Objective: The Gnas transcription unit located within an imprinting region encodes several proteins, including the G-protein a-subunit, Gsa, its isoform XLas and their variant truncated neural forms GsaN1 and XLN1. Gsa and GsaN1 are expressed predominantly from the maternally derived allele in some tissues, whereas XLas and XLN1 are expressed exclusively from the paternally derived allele. The relative contribution of full-length Gsa and XLas, and truncated forms GsaN1 and XLN1 to phenotype is unknown. The edematous-small point mutation (Oed-Sml) in exon 6 of Gnas lies downstream of GsaN1 and XLN1, but affects full-length Gsa and XLas, allowing us to address the role of full-length Gsa and XLas. The aim of this study was therefore to determine the metabolic phenotypes of Oed and Sml mice, and to correlate phenotypes with affected transcripts. Methods: Mice were fed standard or high-fat diets and weighed regularly. Fat mass was determined by DEXA analysis. Indirect calorimetry was used to measure metabolic rate. Glucose was measured in tolerance tests and biochemical parameters in fasted plasma samples. Histological analysis of fat and liver was carried out post mortem. Results: Oed mice are obese on either diet and have a reduced metabolic rate. Sml mice are lean and are resistant to a high-fat diet and have an increased metabolic rate. Conclusion: Adult Oed and Sml mice have opposite metabolic phenotypes. On maternal inheritance, the obese Oed phenotype can be attributed to non-functional full-length Gsa. In contrast, on paternal inheritance, Sml mice were small and resistant to the development of obesity on a high-fat diet, effects that can be attributed to mutant XLas. Thus, the neural isoforms, GsaN1 and XLN1, do not appear to play a role in these metabolic phenotypes.
Introduction
If we are to solve the modern epidemics of obesity and diabetes, a full understanding of the regulation of energy metabolism is required. The Gnas locus on human chromosome 20 and mouse chromosome 2 has a role in glucose and fat metabolism. The Gnas locus is a complex transcription unit located within the distal mouse chromosome 2 imprinting region ( Figure 1 ). The Gnas locus encodes multiple protein-coding transcripts and is subject to regulation by imprinting. 4 One transcript called Gnas gives rise to the guanine-binding a-subunit, Gsa, which couples to the hormone receptors of adenylate cyclase to catalyze the synthesis of intracellular cAMP for signaling. 4 The Gnas transcript is biallelically expressed in most tissues with the exception of the white and brown adipose tissues (WAT and BAT, respectively) and in the renal proximal tubules, in which it is expressed preferentially from the maternal allele. A larger transcript Gnasxl is only expressed from the paternal chromosome. 5 This transcript begins at the upstream exon XL and then splices into exon 2 of Gnas and gives rise to a protein XLas. Apart from the first exon, Gnasxl and Gnas use the same downstream exons. 5, 6 XLas differs from Gsa by the replacement of the first 47 amino acids with a larger N-terminal domain, and shares many properties with Gsa, including the activation of adenylate cyclase, although coupling with hormone receptors has not been shown. 7 Neural-specific transcripts of Gnas (GsaN1) and Gnasxl (XLN1) that transcribe through a novel neural exon located between exons 3 and 4 and terminate prematurely are known. 8, 9 In addition, the Gnasxl first exon contains a second open reading frame (ORF) that begins downstream of the XLas start codon, is shifted by þ 1 nucleotide and terminates at the end of the exon. 10 This ORF encodes Alex, a protein of unknown function. 10 A neuroendocrine-specific transcript called Nesp has been described, which has been shown to have two 5 0 -specific exons located upstream of the Gnasxl first exon. As with the Gnasxl transcript, Nesp splices into exon 2 of Gnas and uses all further downstream exons. The second exon of Nesp is the ORF for the neuroendocrine secretory protein NESP55, a chromogranin-like protein, in a distinct ORF from Gsa. Nesp is expressed exclusively from the maternal allele 4, 5 (Figure 1 ).
A number of mouse knockouts have been constructed, which affect the expression of the protein-coding transcripts and their phenotypes summarized in Tables 1 and 2 .
An ethylynitrosourea-induced mutation; edematous-small (Oed/Sml) has been described and is a missense V159E mutation in exon 6 of the Gnas gene. 14, 15 It is likely that the mutation leads to non-functional Gsa, because mice with a non-functional maternal Gnas allele are resistant to parathyroid hormone 13 as are Oed mice. 16 The phenotypes of the exon 6 mutation have mostly been investigated between birth and weaning. Maternal inheritance of the mutation (Gnas Oedsml-mat ), thus affecting the Gnas transcript encoding Gsa, results in the Oed phenotype with gross oedema, increased adiposity and microcardia. 14 It should be noted that all the targeted mutations published thus far lead to loss of both the full-length and neural-specific truncated forms of Gsa and XLas. The contribution of truncated forms to the phenotypes is thus unclear. The Oed-Sml exon 6 mutation should affect the fulllength Gnas and Gnasxl transcripts but not the neural GsaN1 and XLN1 transcripts that terminate in exon 4. Thus, the Oed-Sml exon 6 mutation allows us to address the role of the full-length transcripts and to infer the role that the truncated transcripts may play, by comparison with data published on the targeted mutants. Here, we describe extensive metabolic phenotyping of adult Oed and Sml mice. By testing the metabolic phenotype of these mice on a high-fat diet, we further investigated whether these mutations protect or predispose the mice to obesity and diabetes.
We have found that Oed mice are predisposed to obesity and that Sml mice are resistant to the development of obesity on a high-fat diet. Similarities with the phenotypes of knockout mutations of the Gnas locus allow us to conclude that these metabolic effects are due to the loss of functional Figure 1 Schematic overview of the mouse Gnas cluster showing neural isoforms. Features of the maternal (Mat) and paternal (Pat) alleles are shown above and below the line, respectively. Protein coding exons are shown as filled boxes and non-coding exons as open boxes. Exon 6 that contains a point mutation in Oed-Sml is marked by *. The arrows show initiation and direction of transcription. Transcription of Gnas from the paternal allele is shown as a dotted line to indicate that its promoter is inactive in some tissues. Splice patterns of maternal and paternal transcripts are shown above and below the line, respectively. Exon N1 is an alternative terminal exon for neural-specific transcripts GsaN1 and XLN1. Although at least 50 different transcripts have been identified in the cluster, 1 for simplicity only the splice variants relevant to the text are shown above and below the line. Protein coding transcripts are shaded. The Nespas and Ex1A transcripts are non-coding. Maternally and paternally methylated regions are shown by ' þ ' symbols above and below the line, respectively. The figure is not to scale (adapted from Plagge et al. 2 and Peters et al. 3 ).
G-protein a-subunit isoforms modulate obesity ML Kelly et al Gsa in Oed mice and due to the loss of functional XLas in Sml mice. Thus, the neural isoforms, GsaN1 and XLN1, do not appear to play a role in these metabolic phenotypes. However, XLN1 may have a role in the suckling behavior, for this activity is impaired in a targeted mutant with intact Alex but lacking XLN1 and full-length Gnasxl transcripts, 13 whereas suckling is not affected in Sml mice.
Methods
Animal generation and husbandry Sml mice with paternal inheritance of the mutation were generated by crossing females of our standard laboratory stock 3H1A with Sml male mice. Sml female mice were crossed with M.m. castaneus males (MCA) to produce Oed G-protein a-subunit isoforms modulate obesity ML Kelly et al mice with maternal inheritance of the mutation. This was necessary because Oed is almost lethal on the 3H1A background but shows greatly improved survival on the MCA background, 14 whereas Sml survives on 3H1A background but cannot be maintained on MCA background. Thus, the background of the Sml mice was entirely 3H1A, whereas the background of Oed was half 3H1A and half MCA. Only male mice were used in these studies. Specific pathogen-free mice were housed in individually ventilated cages under a 12-h light/12-h dark cycle, temperatures of 21±2 1C and humidity of 55±10% in accordance with UK Home Office Welfare Guidelines. Mice were fed ad libitum on either a diet containing 11.5 kcal% fat (SDS, RM3 diet) or a high-fat diet containing 45 kcal% fat (D12451, Research Diets, New Brunswick, NJ, USA) with free access to water (25 p.p.m. chloride).
Genotyping
Genomic DNA was extracted from mouse ear biopsies using a Qiagen DNeasy Tissue Kit in accordance with the manufacturer's instructions. Mice were genotyped by the presence of the exon 6 point mutation using pyrosequencing. Primer sequences can be supplied upon request.
Weight and body mass index
Male mice were aged up to 8 weeks either on a standard diet or on a high-fat diet. Weekly from 8 weeks of age, the weight of the animal was taken along with a measurement of length taken from the tip of the nose to the base of the tail. Body mass index was calculated using the following equation: weight (g)/(length (cm)) 2 .
Suckling activity
Suckling activity was measured on postnatal day 5. Each mouse in the litter was weighed and replaced in the nest; the mother was separated from her litter for 2 h. Just before the mother was replaced, each mouse in the litter was reweighed to give the food-deprived weight. Each mouse was reweighed 1 and 2 h after replacement of the mother, and the difference in weight from the food-deprived weight was taken as a measure of milk intake. The weight difference expressed in terms of food-deprived weight was taken as the measure of suckling activity.
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Metabolic caging At 9 weeks of age, mice were individually housed in metabolic cages for a 24-h period, during which time they had free access to a known amount of food and water. After 24 h, the amount of food and water consumed was measured along with the volume of urine produced. After housing in metabolic cages, the mice were returned to their home cage. For a fuller protocol, see EMPReSS (the European Phenotyping Resource for Standardised Screens from EUMORPHIA; http://empress.har.mrc.ac.uk).
DEXA analysis
At 7 and 12 weeks of age, mice were weighed and given a recoverable general anesthetic before being scanned using a General Electric Medical Systems Lunar PIXImus II X-ray densitometer (Inside Outside Sales, Fichburg, WI, USA), which allows the fat and lean mass and bone density to be calculated. Mice were placed in a heated box to aid recovery; once fully recovered, mice were returned to their home cage.
Metabolic rate measurements At 10 weeks of age, the mice were investigated using indirect calorimetry (Oxymax, Columbus Instruments, Columbus, OH, USA.). Mice were weighed and then individually housed in the equipment for a period of 24 h, with food and free access to water. After testing, the mice were returned to their home cage. Indirect calorimetry allowed the oxygen consumption, carbon dioxide production, respiratory exchange ratio and heat production to be measured.
Intraperitoneal glucose tolerance test
At 12 weeks of age, mice were subjected to fasting overnight. The weight of the mouse was taken and a fasted (T ¼ 0) blood sample collected by tail venipuncture under local anesthesia (Lignocaine), using Lithium-Heparin microvette tubes (Sarstedt, Leicester, UK). The mice were then injected intraperitoneally with 2 g of glucose in 0.9% NaCl per kg body weight, further blood samples were taken at 60 and 120 min after injection. The blood samples were centrifuged at 3000 g for 10 min to obtain plasma. Plasma glucose levels were measured using an Analox Glucose Analyser GM9 (http://empress.har.mrc.ac.uk).
Blood collection for biochemical analysis At 16 weeks of age, mice were fasted overnight. The weight of the mouse was taken and a fasted blood sample collected as described above. Plasma samples were stored at À20 1C until hormone and biochemical analysis (http://empress.har.mrc. ac.uk).
Biochemical analysis of plasma
Plasma collected from the 16-week bleed was analyzed for concentrations of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol and triglycerides. All concentrations were determined using the AU400 analyser (Olympus, Watford, UK) (http://empress.har.mrc.ac.uk).
Detection of cAMP levels At 17 weeks of age, mice were killed using an overdose of anesthesia. Tissues were removed and flash-frozen in liquid nitrogen. Tissues were then stored at À70 1C until use. Tissue was homogenized in 0.1 M HCl; the homogenate was centrifuged at 2000 g for 10 min and the supernatant was G-protein a-subunit isoforms modulate obesity ML Kelly et al used in a Direct cAMP Enzyme Immunoassay (Sigma, Gillingham, UK) following the manufacturer's instructions. All cAMP levels were normalized for protein levels, which were obtained using a Bradford assay.
Histology
At 17 weeks of age after killing as described above, liver samples were collected and fixed in 4% buffered formalin.
Statement of ethics
Research was approved by the local ethics committee and performed in accordance with the Animal (Scientific Procedures) Act 1986.
Results
Mice carrying either the maternal (Oed) or the paternal (Sml) mutation of the Gnas locus were weaned at 4 weeks of age onto either a standard diet or a high 45 kcal% fat diet. From 8 weeks of age, the body weight of each individual was measured every week up to 17 weeks (Figures 2 and 5 ). Cohorts of mice for Dual Energy X-ray Absorptiometry (DEXA) and indirect calorimetry analysis were also weighed from 4 weeks of age and transferred onto a high-fat diet at 7 weeks of age ( Figure 2a ).
Oed mice are obese on a standard or high-fat diet At 4 weeks of age, mice carrying the maternal-derived Oed mutation of Gnas (Gsa) were the same weight as their littermate controls. However, their weights diverge after this and are significantly different from 5 weeks (n ¼ 10 each, weeks 5 and 6 Po0.05, weeks 7-9 Po0.01, weeks 10-12 Po0.001; Figure 2a) . Similarly, in the cohorts of mice weighed from 8 weeks of age, Oed mice were found to be significantly heavier than their wild-type littermates when maintained on either a standard or a high-fat diet with the mutant mice being B7 or 10.8 g heavier on each diet, respectively, at 17 weeks (Figure 2b ). When challenged with a high-fat diet, Oed mutant mice became increasingly more obese compared with Oed mice on a standard diet, and by 17 weeks are 413 g heavier (Figure 2b ). Wild-type littermates on a high-fat diet also become obese compared with wild types on a standard diet and by 17 weeks are nearly 10 g heavier (Figure 2b) . Analysis of the food intake of the Oed mice compared with that of wild-type littermates revealed that the Oed mice had a tendency to consume less food than their wild-type littermates on either diet, although the levels did not reach significance (data not shown).
Adiposity is increased in Oed mice DEXA analysis showed that the percentage fat mass in Oed mice is significantly higher than in wild-type littermates on both diets (Figure 3a) . On a standard diet at 17 weeks, Oed mice were found to have more inguinal WAT fat pad mass compared with their wild-type littermates (Figure 3b ). On both a standard diet and high-fat diet, BAT weight was higher in Oed mice compared with that in wild-type littermates (Figure 3b ). In contrast, cAMP levels were significantly (Po0.001) lower in BAT weeks on a standard diet (SD), after which they were transferred to a high-fat diet (HFD) for 5 weeks and re-analyzed at 12 weeks for the HFD data point (n410). G-protein a-subunit isoforms modulate obesity ML Kelly et al wild-type littermates, indicating a reduced metabolic rate (Figures 3c and d) .
G-protein
Oed mice have normal glucose tolerance Mice were challenged after an overnight fast with a measured weight-dependent intraperitoneal glucose load and the plasma glucose response monitored over a period of 120 min. Apart from mildly reduced fasting plasma glucose in Oed mice on both diets compared with that in controls (Po0.05), there were no significant differences in glucose tolerance (data not shown).
Oed biochemistry
Comparison of Oed and wild-type littermates on both diets at 16 weeks of age after a 16-18 h overnight fast did not reveal any significant differences for total plasma cholesterol, HDL cholesterol and triglycerides. However, low-density lipoprotein cholesterol was elevated on a standard diet in Oed mice (0.734 ± 0.07 (s.e.) (n ¼ 9), 0.54 ± 0.05 mmol l
À1
(s.e.) (n ¼ 11), Po0.05) but not on a high-fat diet.
Oed mice exhibit liver cell steatosis and ballooning degeneration At 17 weeks of age five Oed mice maintained on the high-fat diet along with five wild-type littermates underwent a postmortem examination, the same number of mice were also examined from the groups maintained on the standard diet. When liver tissue was compared, it was found that Oed mice on a standard diet showed signs of mild steatosis, which was not observed in the livers of the wild type mice on the same diet (Figures 4a and b) . When the mice were challenged with G-protein a-subunit isoforms modulate obesity ML Kelly et al a high-fat diet, a greater extent of microvesicular steatosis and ballooning degeneration were observed in the Oed mice compared with that in wild-type littermates (Figure 4c ). Evidence of hydronephrosis was observed in the kidneys of the Oed mice but not wild-type littermates when maintained on either diet (n ¼ 15 and 10, respectively, on a high-fat diet and 12 and 12, respectively, on a standard diet; Figure 4d ). When biochemical analysis was carried out on the urine of these mice, there was found to be no reduction in renal function (data not shown).
Sml mice are protected from obesity As expected, owing to the growth-retarding effect of the Sml mutation, 14 when maintained on either a standard or highfat diet, Sml mice are significantly lighter (Po0.005, data not shown), and shorter (Po0.001, data not shown) and have a lower body mass index (Po0.01, data not shown) than their wild-type littermates. Strikingly, Sml mice carrying the paternally derived Sml mutation of Gnasxl (XLas) were protected from obesity. There was no significant weight difference at any age between Sml mice maintained on a standard diet and Sml mice on a high-fat diet (Figure 5a ). This was particularly obvious up to 11 weeks of age, after 7 weeks on a high-fat diet, where the difference in mean weight was o2 g at any time point. Some non-significant differences in weight occurred at the 12-week time point when mice were fasted overnight as part of a glucose tolerance test. Wild-type littermates maintained on a highfat diet were found to be significantly heavier at all time points (Po0.005) than those on a standard diet (Figure 5b) 17 No significant differences were found (data not shown).
Adiposity is decreased in Sml mice on a high-fat diet DEXA analysis showed that on a high-fat diet, Sml mice were leaner with 31.87 ± 7.49% fat compared with 40.56 ± 6.14% fat in wild-type littermates (Po0.05, Figure 6a ), although there was no significant difference in fat mass between Sml and wild-type mice on a standard diet. When corrected for body weight to take account of size differences, the amount of inguinal WAT found in Sml mice maintained on a high-fat diet was found to be significantly higher than in their wildtype littermates, although this was not observed on a standard diet or in comparison with Sml mice on a standard diet. The amount of BAT found in the Sml mice when maintained on either diet was not significantly different to that of control littermates after correcting for body weight. However, wild-type mice significantly (Po0.01) increased their BAT mass on a high fat-diet (Figure 6b ). When the levels of cAMP were measured in the BAT of the Sml mice, no significant difference was observed on either diet when compared with those in wild-type littermates (data not shown).
Sml mice have a higher metabolic rate Measurement of oxygen consumption and carbon dioxide production over 24 h by indirect calorimetry showed that Sml mice had a significantly higher metabolic rate per kg body weight on both diets compared with wild-type littermates (Figures 6c and d, Po0.05 ). The metabolic rate of both Sml and wild-type littermate mice significantly decreased on a high-fat diet compared with that on a G-protein a-subunit isoforms modulate obesity ML Kelly et al standard diet (P ¼ 0.001). The oxygen consumption of Sml mice on a high-fat diet was similar to that of wild-type mice on a normal diet, although CO 2 output was significantly lower for Sml mice.
Sml mice exhibit mild hypoglycemia Wild-type littermates fed a high-fat diet develop mild impaired glucose tolerance in comparison with Sml mice on either a high-fat (Po0.05 at all time points) or standard G-protein a-subunit isoforms modulate obesity ML Kelly et al diet (Po0.05 at all time points, Figure 7a) . Similarly, wildtype littermates on a high-fat diet compared with wild-type littermates on a standard diet are more glucose intolerant at 60 and 120 min (Po0.01), although they have similar levels of fasting glycemia (Figure 7a ). However, Sml mice on either diet are not significantly different in glucose tolerance (Figure 7a) . We have also found that after a 16-18 h overnight fast, Sml mice maintained on a standard diet had lower concentrations of plasma glucose at all ages tested (Figure 7b ). The average overnight fasted plasma blood glucose concentration, determined from the mean of each animal over the 8 weekly age points, was for wild-type mice 7.53 ± 1.35 mM (n ¼ 12) and for Sml mice 5.96 ± 1.27 mM (n ¼ 12), and were significantly different from each other at Po0.01.
Sml biochemistry Levels of total cholesterol and HDL cholesterol were reduced in the plasma of the Sml mice compared with those of wild-type littermates with a significant decrease (Po0.05) being observed when the mice were maintained on a highfat diet (total cholesterol: 3.37 mmol l À1 ± 0.27 s.e., n ¼ 8 Sml mice exhibit mild steatosis on a high-fat diet At 17 weeks of age, five Sml mice maintained on the high-fat diet along with five wild-type littermates underwent a postmortem examination, the same number of mice were also examined from the groups maintained on the standard diet. Macrovesicular steatosis was observed to a greater extent in the livers of the Sml mice when maintained on a high-fat diet compared with that of the Sml mice on a standard diet and the wild-type mice on either diet (Figures 4 e and f and data not shown). No histological differences were observed in the Sml mice in the stomach and the intestines (data not shown).
Discussion
The most striking observations from the comparison of Oed and Sml mice and their maternal and paternal inheritance of the exon 6 mutation were the resistance of Sml mice to obesity caused by a high-fat diet and the increased obesity of Oed mice on either diet. The resistance to a high-fat diet suggests that Sml mice should have a higher metabolic rate compared with their wild-type littermates. Yu et al.
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reported that females with an exon 2 knockout inherited paternally consume more oxygen. Similarly, Xie et al.
9
describe an XLaS knockout mutation inherited paternally (eliminating XLaS as does the Sml mutation) with reduced fat mass, increased food intake and increased metabolic rate. Similarly, when the metabolic rate of the Sml mice was investigated over 24 h, it was found that there was a significant increase in oxygen consumption and carbon dioxide production in Sml mice compared with that in wild-type littermates. Gsa has been shown to be involved in the regulation of the production of cAMP; 18, 19 it has also been proposed that XLas is an antagonist of Gsa. For example, this may mean that Gsa is responsible for the production of cAMP and XLas for suppression of cAMP levels. If this proposition is the case, then in mice harboring a mutation affecting Gsa (Oed mice) should show a decrease in the levels of cAMP observed, and indeed this was observed in BAT. Mice harboring a mutation affecting Gnasxl (Sml mice) should show an increase in the amount of cAMP observed, because the proposed mechanism for regulating cAMP levels is compromised. However, when the levels of cAMP in BAT of Sml mice were measured, no significant difference was found and similarly the amounts of BAT were not changed either. Xie et al. 9 showed
that XLalphas is not expressed in the adipose tissue of adults, this could be a possible explanation as to why there is not a difference in cAMP levels in the adipose tissue of the Sml mice compared with that of wild-type littermates. The increase in metabolic rate could also reflect metabolic activity in other tissues, such as the liver and muscle.
A comparison of the phenotypes of the published knockouts and the Oed/Sml phenotypes described here are summarized in Tables 1 and 2 . Clearly, there are similarities in the phenotypes seen in the paternally inherited exon 1 knockout, the maternally inherited exon 1 and 2 knockout mutations and of the Oed point mutation. Features in common can be attributed to partial loss of Gsa in tissues in which Gnas is biallelically expressed. There are even closer similarities in the phenotypes seen on maternal inheritance of the exon 1 and exon 2 knockouts and the Oed point mutation, and these extra common features can be ascribed to the loss of functional Gsa in tissues in which Gnas is preferentially maternally expressed. The exception is the improved glucose tolerance in the exon 2 knockout, whereas there is a decreased glucose tolerance in both paternal and maternal inheritance of the exon 1 knockout, and in our case, we were unable to detect a significant difference on maternal inheritance of the Oed mutation. Chen et al. 8 have suggested that other unidentified maternal gene products may exist to explain the puzzling glucose tolerance phenotype of the maternally inherited exon 2 knockout mutation. Similarly, paternally inherited mutations affecting Gnasxl (the Gnasxl and exon 2 knockouts, and the Sml point mutation) all have similar phenotypes. Hence can we say that Sml is likely to result in non-functional Gnasxl and nonfunctional XLas? The similarities observed between these three phenotypes show that Gnas and Gnasxl balance each other metabolically, and that when the former or latter is lost, obesity or leanness results. Owing to the location of the Oed/Sml mutation, transcripts terminating in the intermediate neural exon are not likely to be involved in these phenotypes (see Figure 1) , and the metabolic phenotypes observed in the Oed-Sml can be attributed to the loss of functional full-length Gsa and full-length XLas.
A prominent feature on paternal inheritance of both Gnasxl and exon 2 knockouts is a perinatal feeding failure, but no such defect was observed in Sml mice. Thus, the neural isoform XLN1 probably does have a role in sucking behavior.
Imprinting of Gnas has a significant role in the development of obesity in the mouse. Obesity associated with the loss of Gnas is more severe on maternal inheritance of a nonfunctional allele than on paternal inheritance. These findings have prompted re-examination of obesity found in patients with Albright's hereditary osteodystrophy (AHO), a disorder caused by heterozygosity for inactivating mutations in GNAS (MIM no. 103580). A recent study has shown that obesity is more pronounced in patients with maternal inheritance of an inactivating GNAS mutation than in those with paternal inheritance. 20 Thus, imprinting of GNAS/Gnas leads to significant obesity in both humans and mice. From our study, we predict that loss of maternally derived fulllength GNAS is the cause of the severe obesity.
Besides the Gnas locus, mouse studies have shown that altered expression of genes in five other imprinted clusters results in adult obesity (reviewed in Frontera et al.
21
). Thus, obesity is associated with overexpression of the paternally expressed Peg1/Mest gene, with the loss of paternal expression of Peg3, Igf2 and Dlk/Pref1, and with the loss of maternal expression of Atp10c. Imprinting is associated with obesity in two other human conditions, Prader-Willi syndrome (MIM no. 162270) and Angelman syndrome (MIM no. 105830), where it may be due to the loss of maternally expressed ATP10C. Thus, misexpression of imprinted genes may make a significant contribution to human obesity.
In conclusion, we have shown that a paternally inherited mutation of Gnas protects the individual from the effects of obesity and hyperglycemia, probably through an increased metabolic activity. In contrast, a maternally inherited mutation of Gnas predisposes the individual to the effects of a high-fat diet (obesity) because of a reduced metabolic rate. The location of the mutation is downstream of transcripts, which terminate in neural-specific exons. Therefore, the basis of the observed metabolic phenotypes is not mediated by the neural isoforms of the Gnas locus and therefore presumably rules out a primary central nervous system defect. Xie et al. 9 propose that the metabolic changes are mediated by sympathetic nervous system activity; 9 our results suggest that such mediation could occur through fulllength Gsa and XLas.
